Robin Emigh, RPh, MBA, Vice President, Chief Scientific Officer
Robin has assumed various leadership roles regarding project management, market research, and publishing since joining EMRON 21 years ago as a sales director. Robin guided the evolution of the Novartis Pharmacy Benefit Report from 1996 to 2013 and continues to serve as the managing editor and director of research for the Genentech Oncology Trend Report, a position she has held since 2009. In this capacity, she works with the publication’s board of advisors, directs content planning and research, and participates in data analyses, report compilation, and design.
In her roles at EMRON, she has examined the business of science from various payer and provider perspectives across a number of therapeutic areas, including oncology, cardiovascular, behavioral health, endocrine, gastrointestinal, and women’s health. She works with a talented group of professionals in the delivery of customized solutions that address an ever-evolving health care landscape.
Robin’s diverse background includes clinical operations as a hospital pharmacy director, program development at American Pharmaceutical Association, and research and standards-setting for electronic data interchange, bar coding, and security initiatives at the National Wholesale Druggists’ Association.